{
"NDC": {
"NDCCode": "76282-738-30",
"PackageDescription": "30 TABLET in 1 BOTTLE (76282-738-30) ",
"NDC11Code": "76282-0738-30",
"ProductNDC": "76282-738",
"ProductTypeName": "HUMAN PRESCRIPTION DRUG",
"ProprietaryName": "Darunavir",
"ProprietaryNameSuffix": null,
"NonProprietaryName": "Darunavir 800 Mg",
"DosageFormName": "TABLET",
"RouteName": "ORAL",
"StartMarketingDate": "20240119",
"EndMarketingDate": null,
"MarketingCategoryName": "ANDA",
"ApplicationNumber": "ANDA206288",
"LabelerName": "EXELAN PHARMACEUTICALS INC.",
"SubstanceName": "DARUNAVIR HYDRATE",
"StrengthNumber": "800",
"StrengthUnit": "mg/1",
"Pharm_Classes": "Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], HIV Protease Inhibitors [MoA], Protease Inhibitor [EPC]",
"DEASchedule": null,
"Status": "Active",
"LastUpdate": "2024-01-23",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20261231",
"StartMarketingDatePackage": "20240119",
"EndMarketingDatePackage": null,
"SamplePackage": "N"
}
}